Exhibit 99.2
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Unless the context otherwise indicates, as used in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (“MD&A”), the terms “we,” “us,” “our,” “General Fusion,” the “Company” and similar terms refer to General Fusion Group Ltd. and its consolidated subsidiaries. The following MD&A provides information which General Fusion’s management believes is relevant to an assessment and understanding of General Fusion’s consolidated results of operations and financial condition. This MD&A should be read together with the unaudited interim condensed consolidated financial statements and the related notes for the three and nine month periods ended September 30, 2026 and September 30, 2025 (the “Consolidated Interim Financial Statements”) and the audited consolidated financial statements and the related notes of General Fusion Inc. (“Old General Fusion”) for the years ended December 31, 2025, and 2024 included in our Registration Statement on Form F- 1 (the “F-1”) filed with the U.S. Securities and Exchange Commission (“SEC”) on September 8, 2026. This MD&A may contain forward-looking statements based upon current expectations that involve risks and uncertainties. General Fusion’s actual results may differ materially from those anticipated in these forward-looking statements, including those set forth under “Cautionary Note Regarding Forward-Looking Statements” in this MD&A, as a result of various factors including those set forth under “Risk Factors” in our F-1.
Our Consolidated Interim Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the SEC for interim financial statements. All references to $ or dollar herein are to U.S. dollars. All references to CAD are to Canadian dollars.
The Company uses certain non-GAAP financial measures in this MD&A. None of these measures are standardized financial measures under U.S. GAAP and these measures may not be comparable to similar financial measures disclosed by other issuers. See section “Non-GAAP Measures” below for a discussion of the specified financial measures used in this document and a reconciliation to the most directly comparable U.S. GAAP measures.
This MD&A is dated November 16, 2026, and was prepared with information available to this date.
Additional information relating to the Company is available on SEDAR+ at www.sedarplus.com and on EDGAR at www.sec.gov.
The Business
Overview
General Fusion is a fusion technology development company. The Company’s mission is to commercialize fusion energy. General Fusion aims to deliver economical, carbon-free fusion energy in the next decade through its approach to Magnetized Target Fusion (“MTF”) technology, an engineering-driven approach to fusion energy.
MTF combines magnetic confinement with rapid mechanical compression to achieve fusion conditions. In MTF, relatively weak magnetic fields are used to provide initial plasma confinement, while mechanical compression supplied by a metal-based system provides the necessary heating and density increase. This creates an operating regime in which a pre-heated magnetized plasma is compressed quickly enough to reach fusion conditions before significant energy loss occurs, supporting a practical and scalable means of converting that energy into usable power. To that end, General Fusion has developed a commercial concept for a General Fusion MTF fusion machine, referred to as a “Fusion Island” designed to be integrated with a conventional steam turbine balance-of-plant infrastructure.
As currently designed, General Fusion’s Fusion Island’s concept incorporates a proprietary liquid metal wall technology and relatively low-speed compression (milliseconds) as compared to other types of plasma compression technologies (microseconds or nanoseconds). This slower compression is expected to enable the Fusion Island to achieve fusion conditions using less power, less complexity, and lower cost. The Company’s commercial concept is designed to address long-standing barriers to commercial fusion power: durability, fuel cycle, energy capture and cost.
Each Fusion Island is expected to produce 150 MWe net electricity, with a reference power plant configuration of 300 MWe net electricity consisting of two Fusion Islands integrated with a conventional balance of plant.
1
General Fusion’s potential customers and early adopters are expected to include electric utilities, independent power producers, state-owned enterprises, energy developers, hyperscalers, and industrial companies seeking firm, low-carbon electricity and process heat.
As currently contemplated, General Fusion expects to operate an asset-light, high-margin original equipment manufacturer business model focused on its core fusion technology and intellectual property by supplying the Fusion Island and related systems, while an engineering, procurement, and construction partner will manage overall plant construction, supplier coordination, and contractor execution on behalf of the plant owner.
After installation, General Fusion plans to use a recurring services model that delivers long-term revenue for the Company. Among other services, this model will include the periodic replacement and refurbishment of Fusion Island equipment, such as plasma injectors, as well as ongoing technical support for the fusion system and associated components.
Path to Commercial Fusion Power
The Company’s approach to achieving commercial fusion power consists of four distinct components: science, engineering, integration and commercialization. This approach is designed to systematically de-risk the path to practical fusion power and support the Company’s goal to begin operating a first-of-a-kind plant around 2035 (a “FOAK”).
Science
Since 2002, the Company has been advancing its core science and technology using hands-on engineering and experimental validation. General Fusion has built and operated a series of purpose-built testbeds, each designed to demonstrate a number of core subsystems, including plasma compression and performance, and liquid metal wall formation and collapse.
Based on these collective results, in 2025, General Fusion began operating its large scale MTF demonstration machine, Lawson Machine 26 (“LM26”). LM26 represents the Company’s largest, most advanced and integrated demonstration system to date.
The LM26 MTF demonstration machine is designed to validate key elements of the Company’s approach to MTF by achieving key technical milestones, including: plasma heating to 1 keV electron temperature, or approximately 10 million degrees Celsius, then 10 keV temperature, or approximately 100 million degrees, and ultimately, the Lawson criterion. For General Fusion’s approach in LM26, achieving the Lawson criterion means simultaneously demonstrating, using deuterium-deuterium (D-D) fuel, the temperature, density and energy confinement time which when combined corresponds to the operating conditions required for deuterium-tritium (“D-T”) plasma to achieve fusion power in excess of the rate of heat loss.
LM26 uses a solid lithium liner compressed by theta-pinch coils. A Marshall gun injects a magnetized deuterium-deuterium (“D-D”) plasma into the cavity formed by the liner, after which pulsed magnetic coils implode the liner, trapping and compressing the plasma. This configuration enables MTF plasma physics validation without the complexity and cost associated with liquid rotor systems or tritium handling.
On October 8, 2026, the Company announced that it reached electron temperatures of approximately 1.1 keV, or 12.6 million degrees Celsius, just prior to peak compression, a result measured using Thomson scattering and in collaboration with the UK Atomic Energy Authority (“UKAEA”). In addition, the Company’s absolute extreme ultraviolet (“AXUV”) diagnostic data closely aligned with the Thomson scattering heating trend and measured electron temperatures of approximately 1.2 keV, or 13.7 million degrees Celsius, during peak compression, a deeper point at which Thomson scattering measurement is not available. During compression, the Company also observed ion heating to approximately 0.46 keV, up to a twofold increase above starting ion temperature. Ion temperature is inferred through both a measurement of neutron yield and plasma density profile and through time-dependent reconstruction of diagnostic data.
2
The Thomson scattering result, measured in collaboration with the UKAEA is detailed in a technical paper co-authored by UKAEA that has been submitted for peer review. The Company’s AXUV temperature measurement and ion heating results are detailed in a separate technical paper, also submitted for peer review.
Upgrades to the LM26 machine are now underway to support higher plasma compression ratios required to achieve the second milestone of 10 keV.
Integration and Engineering
The Company is currently preparing to start its commercial systems program in 2027. The objective of the commercial system program is to advance key systems and technologies for a commercial plant, including high repetition rate for key systems and technologies, key liquid metal systems and technologies, key balance of plant systems, and heat exchange systems.
Completion of the commercial systems program is expected to support final plant design and the construction of a FOAK facility, with initial operations targeted for around 2035 and then a broader transition to commercial deployment.
Commercialization
General Fusion’s business plan includes separately but concurrently evaluating potential sites for a FOAK plant and building a market framework such that customer engagement, government support and regulatory frameworks will be mature when its technology is commercialized.
These market development initiatives include government engagement and support, regulatory framework development and engagement with the utility and industrial members of the Company’s Market Development Advisory Committee (“MDAC”). The MDAC consists of 13 potential end users working with the Company on technology development and commercialization efforts including potential siting of a FOAK plant, feasibility, economic analysis, regulatory pathways and operational planning. MDAC participants include major utilities and energy companies such as Bruce Power, Ontario Power Generation, FortisBC, BC Hydro, Duke Energy, Southern Company, the Tennessee Valley Authority, E.ON, ENGIE, Eneco, Renexia, Stegra, and ACEN.
General Fusion has also entered into a number of collaboration and partnership agreements to support its technology development and commercialization activities, including a memorandum of understanding with Bruce Power, a memorandum of understanding with Kyoto Fusioneering, a collaboration agreement with UKAEA, and a memorandum of understanding with a major automaker.
In June 2026, General Fusion announced a phased, milestone-based framework agreement with Renexia S.p.A., a Toto Group company, to collaborate on the potential commercial deployment of the Company’s fusion energy technology in Italy.
Significant Events During the Three and Nine Months Ended September 30, 2026
Business Combination and Private Investment in Public Equity
On January 21, 2026, General Fusion (then known as Spring Valley Acquisition Corp. III (“SVIII”)), Old General Fusion and 1573562 B.C. Ltd., a British Columbia limited company and wholly-owned direct subsidiary of SVIII (“NewCo”) entered into a business combination agreement (as amended on May 12, 2026 and on June 3, 2026, the “Business Combination Agreement”), pursuant to which, among other things, SVIII agreed to acquire all of the issued and outstanding securities of Old General Fusion and Old General Fusion would amalgamate with NewCo (the “Business Combination”).
Concurrently (i) the Company and Old General Fusion entered into securities purchase agreements for a private investment in public equity (“PIPE”) financing pursuant to which investors agreed, among other things, to purchase an aggregate of 10,556,367 units of Old General Fusion at a price of $10.20 per unit, each unit comprising (i) one convertible preferred share of Old General Fusion (the “Old General Fusion Convertible Preferred Shares”); and (ii) one warrant exercisable for a common share of Old General Fusion at a price of $12.00 per share (the “Old General Fusion PIPE Warrants”) for total gross proceeds of $107.7 million (collectively, the “PIPE Subscription Agreements”); and (ii) the lead PIPE investor subscribed for an additional 3,500,000 non-voting Class B common shares of Old General Fusion (the “Commitment Shares”) for gross proceeds of $0.35 million.
3
On July 10, 2026, the Business Combination and the PIPE financing closed.
General Fusion now has four classes of authorized shares, multiple voting shares (“Multiple Voting Shares”), subordinate voting shares (“Subordinate Voting Shares”), class A, B and C earnout shares (the “Class A Earnout Shares”, “Class B Earnout Shares”, “Class C Earnout Shares” respectively, and collectively, the “Earnout Shares”) and preferred shares issuable in series, of which General Fusion only has Multiple Voting Shares, Subordinate Voting Shares and Earnout Shares issued and outstanding.
Pursuant to the Business Combination all common shares of Old General Fusion were exchanged for Subordinate Voting Shares and Earnout Shares, in accordance with the exchange ratio prescribed by the Business Combination Agreement, the Old General Fusion Convertible Preferred Shares were exchanged for Multiple Voting Shares, the Old General Fusion PIPE Warrant was exchanged for a new warrant to acquire Subordinate Voting Shares (the “PIPE Warrants”), the common share options were exchanged for an option to purchase a Subordinate Voting Share and either an option to acquire Earnout Shares (“Earnout Options”) or restricted Earnout Shares (“Restricted Earnout Shares”) in accordance with the exchange ratio prescribed by the Business Combination Agreement and common share purchase warrants (including the Old General Fusion SAFE Warrants, as defined below) were exchanged for warrants to purchase a Subordinate Voting Share and a warrant to acquire Earnout Shares (“Earnout Warrants”) in accordance with the exchange ratio prescribed by the Business Combination Agreement.
In connection with the closing of the Business Combination, Old General Fusion received aggregate net proceeds of approximately $123.3 million, consisting of (i) $104.6 million from the PIPE financing (gross proceeds of $108.0 million less certain transaction costs); and (ii) $18.7 million representing the balance of SVIII’s trust account of $21.7 million, inclusive of accrued interest, together with funds in SVIII’s operating account, less payables remitted at the source and certain transaction costs.
The Business Combination is being accounted for as a reverse recapitalization in accordance with U.S. GAAP, with Old General Fusion identified as the accounting acquirer and SVIII as the acquired company for financial reporting purposes, and the Business Combination is treated as if Old General Fusion issued shares for the net assets of SVIII, accompanied by a recapitalization, with the net assets of SVIII recorded at historical cost and no goodwill or other intangible assets recognized.
On July 13, 2026, the Subordinate Voting Shares and warrants previously issued by SVIII began trading on the Nasdaq under the symbol “GFUZ” and “GFUZW”, respectively.
Simple Agreement for Future Equity
In the fourth quarter of 2025 and January 2026, Old General Fusion closed a simple agreement for future equity financing for gross proceeds of $44.5 million (“SAFE Financing”). Under the SAFEs, investors provide upfront cash in exchange for the right to receive future shares upon the occurrence of specified events. The proceeds of the SAFE Financing consisted of $44.2 million in respect of the SAFE investment and $0.3 million for warrants to purchase Class A common shares of Old General Fusion (“Old General Fusion SAFE Warrants”). In total, Old General Fusion issued 14,681,427 Old General Fusion SAFE Warrants inclusive of 3,625,000 Old General Fusion SAFE Warrants issued as consideration for finders’ fees related to the total SAFE Financing.
The closing of the Business Combination on July 10, 2026, constituted a triggering event under the terms of the SAFEs, and immediately prior to the consummation of the Business Combination, all outstanding SAFEs were converted into common shares of Old General Fusion. Upon closing, those common shares were exchanged for Subordinate Voting Shares and Earnout Shares pursuant to the terms of the Business Combination Agreement. In addition, the Old General Fusion SAFE Warrants were exchanged for 2,538,646 warrants to purchase Subordinate Voting Shares (the “SAFE Warrants”) with the exercise price correspondingly adjusted to reflect the exchange ratio, after giving effect to the anti-dilution adjustment provided for in the Old General Fusion SAFE Warrants.
4
Amended and Restated SRF Contribution Agreement
In March 2026, Old General Fusion and the Government of Canada, through the Strategic Response Fund (“SRF”), entered into an Amended and Restated Contribution Agreement (the “Amended and Restated SRF Contribution Agreement” and the predecessor agreement (as amended), the “SRF Contribution Agreement”).
As consideration for the additional funding available to Old General Fusion under the Amended and Restated SRF Contribution Agreement, Old General Fusion agreed to issue to SRF Class B1 Preferred Share warrants at an issue price of $1.587 per warrant (the “Class B1 Warrants”). For each Class B1 warrant issued, Old General Fusion also agreed to concurrently issue 12.542 Class B3 Preferred Share warrants (the “Class B3 Warrants” and, together with the Class B1 Warrants, the “Preferred Share Warrants”). Each Class B1 Warrant was exercisable into one Class B1 Preferred Share and each Class B3 Warrant was exercisable into one Class B3 Preferred Share, in each case for no additional consideration.
During the nine months ended September 30, 2026, Old General Fusion received $3.6 million (CAD 5.0 million) under the Amended and Restated SRF Contribution Agreement, resulting in the issuance of 2,283,169 Class B1 Warrants and 28,635,504 Class B3 Warrants to SRF. Total cumulative funding contributed from SRF as of September 30, 2026 was $55.1 million (CAD 74.3 million).
In connection with the closing of the Business Combination on July 10, 2026, all outstanding Class B non-voting common share purchase warrants (“SRF Warrants”) issued under the SRF Contribution Agreement and all Preferred Share Warrants issued under the Amended and Restated SRF Contribution Agreement were exchanged for warrants to acquire, for no additional consideration, Subordinate Voting Shares in accordance with the terms of the Business Combination. The SRF Warrants and Preferred Share Warrants were transferred to another Canadian government entity, BDC Capital Inc. (“BDC”), prior to the closing of the Business Combination.
New Management Addition
On November 10, 2026, the Company announced the appointment of David Janashvili as Chief Financial Officer, effective November 30, 2026. For additional information, refer to the Company’s Report on Form 6-K furnished to the SEC on November 10, 2026.
Key Factors that Significantly Affect our Business
Revenue
To date, we have not generated any revenue, and we have incurred losses from operations since our inception. We have primarily funded our operations with the net proceeds from the issuance of redeemable convertible preferred shares, common shares, subordinated voting shares, convertible notes, SAFEs, warrants and government assistance.
We expect to incur significant expenses and operating losses for the foreseeable future as we continue to advance our technology and execute our business plan. We expect our research and development, business development, marketing, communications and government relations, and general and administrative costs will continue to increase significantly, including the costs associated with operating as a public company following the completion of the Business Combination on July 10, 2026, further described above.
Due to the numerous risks and uncertainties associated with the development of our technology, we are unable to accurately predict the timing or amount of increased expenses or the timing of when, or if, we will be able to achieve profitability and cash flows from operations. Even if we generate revenue, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations.
Availability of Financing
Current cash and cash equivalents and short-term investments will be used to fund our planned operations for at least 12 months from the date of this MD&A. Our operations are capital intensive and future capital expenditures are expected to be substantial. As such, we expect the Company to require additional financing as we advance towards commercialization. There is no assurance that the Company will be able to obtain such financings or obtain them on favorable terms.
5
Macroeconomic Environment
Negative conditions in the general economy in Canada, the United States and abroad, including conditions resulting from changes in gross domestic product growth, inflation, interest rates, financial and credit market fluctuations, international trade relations and tariffs, pandemics, political turmoil, natural catastrophes, warfare, and terrorist attacks, could negatively affect our business, including if such factors affect our access to additional capital, progress in the development of our MTF technology. It is not possible at this time to estimate the long-term impact that these and related events could have on our business, as the impact will depend on future developments, which are highly uncertain and cannot be predicted.
Significant Components of Results of Operations
Revenue
To date, we have not generated any revenue and do not expect to generate any revenue from the sale of products or services or from other sources in the near future, if at all.
Research and development
Research and development costs consist primarily of compensation and related costs for personnel, including share-based compensation, materials and consumables, contractor and consultant fees, patent fees, and allocations of overhead costs, such as rent, facilities and information technology. Research and development costs have been expensed as incurred. As we continue to develop our MTF technology, we expect research and development costs to increase.
Business development, marketing, communications and government relations
General Fusion is focused on building a market framework for its planned future commercial fusion power plant design such that customer engagement, government support and regulatory frameworks will be mature when our technology is commercialized. These market development initiatives are currently focused on government engagement and support, regulatory framework development and engagement with the utility and industrial members of the MDAC.
Business development, marketing, communications and government relations costs are predominantly comprised of personnel related expenses, including salaries and benefits and share-based compensation, as well as professional fees and contractors, and office, marketing, and travel costs. We anticipate increases in business development, marketing, communications and government relations costs in the future as we continue to develop our MTF technology and progress towards commercialization.
General and administrative
General and administrative costs consist primarily of compensation and related costs for personnel, including share-based compensation. In addition, general and administrative expenses include third-party consulting, professional fees, insurance, and allocations of overhead costs, such as rent, facilities and information technology.
General Fusion is implementing measures to scale its administrative infrastructure to support the growth of the Company, its commercialization trajectory and its transition to a public company. In respect of this, we are investing in a number of initiatives including an increase in headcount across the finance, human resources, and information technology departments. These initiatives will likely result in a higher general and administrative cost structure in future periods. In addition, we also expect an increase in our general and administrative costs as a result of becoming a public company, including but not limited to regulatory fees, transfer agent fees, professional fees and insurance.
6
Government assistance
As described above, the SRF Contribution Agreement and Amended and Restated SRF Contribution Agreement provided funding for a portion of our eligible research and development expenditures in accordance with its terms.
As consideration for contributions under the Amended and Restated SRF Contribution Agreement, Old General Fusion issued SRF Warrants and SRF Preferred Share Warrants. Funds received under the Amended and Restated SRF Contribution Agreement are recognized as a financial liability recorded at fair value and as government assistance. The portion of those funds related to the financial liability is equal to the fair value of the SRF Warrants and SRF Preferred Share Warrants, adjusted by the contingent repayment feature, with the remaining cash received recognized as government assistance.
Under the terms of the Amended and Restated SRF Contribution Agreement, the Company is subject to events of default, including but not limited to, the Company’s failure to comply with its covenants under the agreement, use of funding for purposes other than those permitted, and insolvency-related events (each, an “Event of Default”). Upon the occurrence of an Event of Default, the Company could be required to pay all or a portion of funding received under the agreement. As the occurrence of certain of those Events of Default is not solely within the Company’s control, the SRF Warrants and the SRF Preferred Share Warrants do not qualify for equity classification and are classified as liabilities in accordance with Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity.
The SRF Warrants and Preferred Share Warrants were exchanged for warrants to acquire Subordinate Voting Shares pursuant to the terms of the Business Combination.
We remain in compliance with all obligations under the Amended and Restated SRF Contribution Agreement.
Loss (gain) on revaluation of SRF contribution liabilities
The SRF contribution liability includes the funding liability and warrant obligation, with the funding liability representing the value of the issued SRF Warrants, SRF Preferred Share Warrants and the contingent obligation to repay contributions in cash upon an Event of Default (the “Contingent Repayment Obligation”). On the closing of the Business Combination, all outstanding SRF Warrants and SRF Preferred Share Warrants were exchanged for warrants to purchase Subordinate Voting Shares of the Company at the exchange ratio.
Amounts reported as the warrant obligation represent the value for contributions received, for which SRF Warrants have yet to be issued. The fair value of the funding liability was estimated using the Probability-Weighted Expected Return Method (“PWERM”), which accounts for the complexity of the dual-settlement nature of the arrangement by assigning probabilities to discrete future outcomes. The value of the Contingent Repayment Obligation that is subject to the PWERM valuation is estimated using a discounted cash flow model.
Loss (gain) on revaluation of SAFE liabilities
The financial statements line item loss (gain) on revaluation of SAFE liabilities includes gains and losses on the revaluation of the SAFEs.
The SAFEs were considered freestanding financial instruments as they were legally detachable and separately exercisable from other instruments and did not meet the criteria to be classified as equity and were measured to their estimated fair value at each financial reporting date. Prior to settlement, the fair value of the SAFEs was estimated using a PWERM, which incorporated assumptions regarding the timing and probability of four mutually exclusive scenarios: SPAC conversion, IPO conversion, change of control event, and dissolution.
The closing of the Business Combination on July 10, 2026 constituted a Liquidity Event under the terms of the SAFEs, and all outstanding SAFEs were converted into Old General Fusion Class A Common Shares immediately prior to the consummation of the Business Combination, and then immediately exchanged for Subordinate Voting Shares at closing of the Business Combination. The SAFEs were remeasured to fair value immediately prior to conversion, based on the number of Subordinate Voting Shares issued to the SAFE holders and the publicly traded price of the Subordinate Voting Shares, with the change in fair value through the settlement date recognized in loss on revaluation of SAFE liabilities and the carrying amount of the liability reclassified to equity upon conversion. No SAFEs remain outstanding as of September 30, 2026.
7
Loss (gain) on revaluation of PIPE subscription obligation
The PIPE subscription obligation represents a freestanding forward sale contract obligating the Company to issue, and the PIPE investors to purchase, the units, comprising redeemable convertible preferred shares and liability-classified warrants, upon satisfaction of the conditions of closing of the Business Combination. The Company’s obligation under the PIPE Subscription Agreements was recognized as a liability in accordance with ASC 480, Distinguishing Liabilities from Equity, and was measured to its estimated fair value at each financial reporting date, with changes in fair value recognized in the consolidated statements of operations and comprehensive loss. Upon issuance of the units immediately prior to the consummation of the Business Combination on July 10, 2026, the forward contract was settled at its then-current fair value, and no PIPE subscription obligation remains outstanding as of September 30, 2026.
The fair value of the PIPE subscription obligation at the date of the agreements and immediately prior to settlement was measured as the difference between the estimated fair value of the preferred shares and warrants to be issued and the contractual subscription proceeds to be received, with the fair values of the preferred shares and warrants estimated using a Monte Carlo simulation method. Key inputs used include the price of the Subordinate Voting Shares, expected volatility, expected term, risk-free interest rate, and weighted average discount rate.
Gain on revaluation of warrant liabilities
The financial statements line item “Gain on revaluation of warrant liabilities” includes gains and losses on the revaluation of the PIPE Warrants (issued as part of the units sold in the PIPE Financing) and the SAFE Warrants.
Each PIPE Warrant is exercisable for one Subordinate Voting Share at an initial exercise price of $12.00 per share, expires five years from issuance, and is subject to a six-month price reset, anti-dilution and down-round adjustments. The Company evaluated the PIPE Warrants under ASC 480, Distinguishing Liabilities from Equity, and ASC 815-40, Derivatives and Hedging, and concluded that, while they are not liabilities within the scope of ASC 480, they do not meet the criteria to be considered indexed to the Company’s own stock because of the adjustment and reversal provisions tied to modifications of other outstanding options or convertible securities. Accordingly, the PIPE Warrants are classified as liabilities and measured to their estimated fair value at each financial reporting date, with changes in fair value recognized in the consolidated statements of operations and comprehensive loss. The fair value of the PIPE Warrants is estimated using a Monte Carlo simulation method, with key inputs including the price of the Subordinate Voting Shares, expected volatility, expected term, risk-free interest rate, and weighted average discount rate.
At the closing of the Business Combination on July 10, 2026, the Old General SAFE Warrants were exchanged for the SAFE Warrants. The SAFE Warrants do not qualify for equity classification and are measured to their estimated fair value at each financial reporting date. Old General Fusion SAFE Warrants were estimated using the Black-Scholes model. As of September 30, 2026, quoted historical share price data was available for the Company’s Subordinate Voting Shares. Accordingly, the fair value of the SAFE Warrants was estimated using a Monte Carlo simulation model, as the exercise price of the SAFE Warrants may be adjusted if the Company’s volume weighted average share price triggers contractual exercise price resets in other equity-linked instruments.
Gain on revaluation of earnout liabilities
The financial statements line-item gain on revaluation of earnout liabilities includes gains and losses on the revaluation of the Earnout Shares and Earnout Warrants issued in connection with the Business Combination. Each class of Earnout Shares will automatically convert into Subordinate Voting Shares on a one-for-one basis if, during the five-year period following closing of the Business Combination (the “Earnout Period”), the volume weighted average price (“VWAP”) of the Subordinate Voting Shares equals or exceeds $15.00 (Class A), $20.00 (Class B) or $25.00 (Class C) for any 20 trading days within any 30 consecutive trading day period (each, an “Earnout Target”), or upon a Deemed Liquidation Event (as defined in the rights and restrictions attached to the Earnout Shares) based on the implied transaction valuation. If an Earnout Target is not achieved during the Earnout Period, the applicable class of Earnout Shares can be redeemed for a nominal amount and cancelled. The Earnout Shares and Earnout Warrants were evaluated under ASC 815-40, Derivatives and Hedging, and, because the Deemed Liquidation Event conversion feature provides for settlement contingent on a transaction valuation that is not an input to the fair value of a fixed-for-fixed option on the Company’s shares, they do not meet the indexation criterion and are classified as liabilities. The Earnout Shares and Earnout Warrants were recognized at their fair value on the closing date of the Business Combination with the offsetting entry recorded in additional paid-in capital as part of the reverse recapitalization. Both the Earnout Shares and the Earnout Warrants are subsequently remeasured to their estimated fair value at each financial reporting date, with changes in fair value recognized in the consolidated statements of operations and comprehensive loss.
8
Earnout Options and Restricted Earnout Shares issued to employees and other service providers are accounted for as share-based compensation under ASC 718 and are presented separately from the earnout liability. The fair value of the Earnout Options and Restricted Earnout Shares is estimated using a Monte Carlo simulation, which models the future path of the Subordinate Voting Share price over the Earnout Period to determine the probability of achieving each Earnout Target and the expected timing of conversion. Key inputs include the fair value of the Subordinate Voting Shares, expected term, expected volatility and risk-free interest rate. Changes in the fair value of the Earnout Options and Restricted Earnout Shares are recognized as share-based compensation expense within loss from operations, and the Earnout Option liability is classified as share-based compensation liability as of September 30, 2026.
Financing costs
The financial statements line item Financing costs includes the portion of the issuance costs of the Business Combination, the PIPE Financing and any other financing that is allocated to liability-classified instruments (including the PIPE Warrants), such as the fair value of securities issued to investors in connection with a financing (including the Commitment Shares) and directly attributable legal and advisory fees. As liability-classified instruments, including the PIPE Warrants, are measured at fair value through earnings, the issuance costs allocated to them are expensed as incurred, whereas the issuance costs allocated to equity-classified instruments, such as the Multiple Voting Shares and Subordinate Voting Shares, are recorded as a reduction of equity.
Gain on revaluation of convertible notes
In accordance with ASC 825-10, Financial Instruments, the Company has irrevocably elected the Fair Value Option (“FVO”) to account for the Convertible Notes in their entirety at fair value. The fair value of the Convertible Notes at issuance and until their settlement in August 2025 was estimated using the Monte Carlo simulation method with key assumptions used including the estimated per share fair value of the Company’s preferred shares, the Company’s credit spread and expected volatility. The estimated fair value of the Convertible Notes at settlement was based on the fair value of the redeemable convertible preferred shares that the notes were exchanged for at maturity.
Results of Operations
We incurred an operating loss during the three months ended September 30, 2026 and the nine months ended September 30, 2026 and September 30, 2025, and operating income during the three months ended September 30, 2025.
Operating loss for the three months ended September 30, 2026 was $12.4 million, compared to operating income of $0.2 million for the three months ended September 30, 2025, due to increases in general and administrative primarily due to higher share-based compensation, professional fees and transaction related costs incurred in connection with the Business Combination, and higher insurance premiums following the Business Combination. Research and development expenses increased primarily due to higher share-based compensation and materials and consumables for LM26 upgrades. Business development expenses increased primarily due to higher marketing, travel and professional fees associated with the go-public process. The prior year period also included a $6.7 million recovery of share-based compensation in general and administrative and research and development expenses related to the revaluation of liability-classified stock options, which drove the operating income in that period and did not recur in the current period.
9
Operating loss for the nine months ended September 30, 2026 increased 300% to $40.5 million, compared to $10.1 million for the nine months ended September 30, 2025, with the increase primarily attributable to increases in general and administrative and research and development expenses and the absence of government assistance in the current period. The increase in general and administrative and research and development expenses was mainly due to an increase in share-based compensation, as the prior year period included a recovery resulting from a decline in the estimated fair value of the Company’s liability-classified stock options following a rights offering completed by Old General Fusion in August 2025 (the “Rights Offering”), which did not recur in the current period. General and administrative expenses also increased due to higher professional fees and transaction related costs incurred in connection with the Business Combination, and research and development expenses also increased due to higher salaries and benefits from increased headcount, as the prior year period reflected the reduced headcount following the May 2025 workforce reduction, and continued investment in the LM26 program.
Adjusted Operating Loss, a non-GAAP financial measure (see “Non-GAAP Measures” below for a definition and a reconciliation to operating loss (income), the most directly comparable U.S. GAAP measure), increased 108% to $11.0 million for the three months ended September 30, 2026, from $5.3 million for the three months ended September 30, 2025. The increase was primarily due to higher professional fees and contractor costs incurred in connection with the Business Combination and associated with the go-public process and operating as a public company, higher salaries and benefits reflecting increased headcount in research and development and general and administrative functions, higher office, marketing, insurance and travel expenses, mainly directors’ and officers’ insurance and business development activities, and higher materials and consumables related to planned upgrades to LM26.
Adjusted Operating Loss increased 55% to $29.5 million for the nine months ended September 30, 2026, from $19.0 million for the nine months ended September 30, 2025. The increase was primarily due to higher professional fees and contractor costs incurred in connection with the Business Combination and associated with the go-public process and operating as a public company, higher office, marketing, insurance and travel expenses for the same reasons discussed above, higher salaries and benefits, and increased research and development expenses related to the ramp up of LM26 operations.
Further details regarding the individual financial statement line items contributing to our operating loss (income) are provided in the subsections below.
The following tables set forth our results of operations for the periods presented. The period-to-period comparisons of financial results are not necessarily indicative of future results.
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
| (in thousands of dollars) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Operating costs | ||||||||||||||||
| Research and development | $ | 5,849 | $ | 1,516 | $ | 18,064 | $ | 10,847 | ||||||||
| Business development, marketing, communications, and government relations | 1,222 | 885 | 3,556 | 2,458 | ||||||||||||
| General and administrative | 4,454 | (3,340 | ) | 16,294 | 539 | |||||||||||
| Depreciation and amortization | 862 | 696 | 2,584 | 2,205 | ||||||||||||
| Government assistance | - | - | - | (5,921 | ) | |||||||||||
| Operating loss (income) | 12,387 | (243 | ) | 40,498 | 10,128 | |||||||||||
| Other Expense (Income) | ||||||||||||||||
| Interest expense | 14 | 224 | 38 | 1,149 | ||||||||||||
| Interest and other income | (1,172 | ) | (136 | ) | (1,866 | ) | (269 | ) | ||||||||
| Financing costs | 11,458 | - | 11,484 | - | ||||||||||||
| Foreign exchange loss (gain) | 2,055 | (86 | ) | 757 | (1,103 | ) | ||||||||||
| Gain on revaluation of convertible notes | - | (22,544 | ) | - | (22,036 | ) | ||||||||||
| Loss (gain) on revaluation of SRF contribution liabilities | (20,714 | ) | (18,026 | ) | 37,328 | (18,970 | ) | |||||||||
| Loss (gain) on revaluation of SAFE liabilities | (2,778 | ) | - | 11,120 | - | |||||||||||
| Loss (gain) on revaluation of PIPE subscription obligation | (1,769 | ) | - | 20,282 | - | |||||||||||
| Gain on revaluation of warrant liabilities | (10,296 | ) | - | (7,952 | ) | - | ||||||||||
| Gain on revaluation of earnout liabilities | (19,384 | ) | - | (19,384 | ) | - | ||||||||||
| Net (income) loss before income taxes | $ | (30,199 | ) | $ | (40,811 | ) | $ | 92,305 | $ | (31,101 | ) | |||||
| Income tax expense | 41 | 25 | 41 | 25 | ||||||||||||
| Net (income) loss for the period | $ | (30,158 | ) | $ | (40,786 | ) | $ | 92,346 | $ | (31,076 | ) | |||||
10
Research and development
A breakdown of the research and development costs for the three and nine months ended September 30, 2026 and 2025 is presented below:
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||
| (in thousands of dollars, except percentage) | 2026 | 2025 | % Change | 2026 | 2025 | % Change | ||||||||||||||||||
| Salaries and benefits | $ | 3,139 | $ | 2,229 | 41 | % | $ | 9,202 | $ | 8,421 | 9 | % | ||||||||||||
| Materials and consumables | 1,490 | 457 | 226 | % | 3,293 | 2,118 | 55 | % | ||||||||||||||||
| Professional fees and contractors | 378 | 196 | 93 | % | 831 | 397 | 109 | % | ||||||||||||||||
| Office and travel | 471 | 259 | 82 | % | 1,507 | 1,037 | 45 | % | ||||||||||||||||
| Software and information technology | 266 | 145 | 83 | % | 582 | 457 | 27 | % | ||||||||||||||||
| Share-based compensation | 105 | (1,770 | ) | n/m | 2,649 | (1,583 | ) | n/m | ||||||||||||||||
| Total | $ | 5,849 | $ | 1,516 | 286 | % | $ | 18,064 | $ | 10,847 | 67 | % | ||||||||||||
n/m = not meaningful
Research and development expenses increased 286% to $5.8 million for the three months ended September 30, 2026, from $1.5 million for the three months ended September 30, 2025, primarily driven by a $1.9 million increase in share-based compensation, as the three months ended September 30, 2025 included a $1.8 million recovery resulting from a significant decline in the estimated fair value of the Company’s liability-classified stock options following the Rights Offering, which did not recur in the current period.
Materials and consumables increased primarily due to planned upgrades to LM26 in support of the Company’s next milestone, compressional heating to 10 keV, whereas spending in the comparative period was limited by the capital constraints in effect at that time. Salaries and benefits increased primarily due to higher average headcount during the three months ended September 30, 2026, as the comparative period reflected the reduced headcount following the workforce reduction in May 2025. Office and travel expenses increased primarily due to a higher allocation of facilities costs to research and development activities and increased travel.
Research and development expenses increased 67% to $18.1 million for the nine months ended September 30, 2026, from $10.8 million for the nine months ended September 30, 2025, primarily due to an increase in share-based compensation, materials and consumables, salaries and benefits, and office and travel compared to the prior year period for the same reasons discussed above.
Business development, marketing, communications and government relations
A breakdown of the business development, marketing, communications and government relations costs for the three and nine months ended September 30, 2026 and 2025 is presented below:
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||
| (in thousands of dollars, except percentages) | 2026 | 2025 | % Change | 2026 | 2025 | % Change | ||||||||||||||||||
| Salaries and benefits | $ | 477 | $ | 343 | 39 | % | $ | 1,460 | $ | 1,206 | 21 | % | ||||||||||||
| Professional fees and contractors | 138 | 22 | 527 | % | 703 | 89 | 690 | % | ||||||||||||||||
| Office, marketing, and travel | 388 | 87 | 346 | % | 849 | 293 | 190 | % | ||||||||||||||||
| Software and information technology | 29 | 3 | 867 | % | 79 | 13 | 508 | % | ||||||||||||||||
| Share-based compensation | 190 | 430 | (56 | )% | 465 | 857 | (46 | )% | ||||||||||||||||
| Total | $ | 1,222 | $ | 885 | 38 | % | $ | 3,556 | $ | 2,458 | 45 | % | ||||||||||||
Business development, marketing, communications and government relations expenses increased 38% to $1.2 million for the three months ended September 30, 2026, from $0.9 million for the three months ended September 30, 2025, primarily driven by increases in office, marketing, and travel expenses due to increased marketing and communications and travel related to the Company’s public listing. As well, salaries and benefits increased primarily due to increased headcount and higher performance incentive awards and professional fees and contractor expenses increased due to fees to external advisors assisting the Company with its go-public marketing program and website design. These increases were partially offset by lower share-based compensation due to the impact of options granted before the decline in the estimated fair value of the Company’s common shares due to the Rights Offering.
11
Business development, marketing, communications and government relations expenses increased 45% to $3.6 million for the nine months ended September 30, 2026, from $2.5 million for the nine months ended September 30, 2025, primarily driven by an increase in professional fees and contractor expenses, mainly due to fees to external advisors assisting the Company with its go-public marketing program and website redesign, office, marketing, and travel, and salaries and benefits, for the reasons discussed above.
General and administrative
A breakdown of the general and administrative costs for the three and nine months ended September 30, 2026 and 2025 is presented below:
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||
| (in thousands of dollars, except percentages) | 2026 | 2025 | % Change | 2026 | 2025 | % Change | ||||||||||||||||||
| Salaries and benefits | $ | 1,495 | $ | 999 | 50 | % | $ | 3,830 | $ | 3,238 | 18 | % | ||||||||||||
| Professional fees and contractors | 1,850 | 187 | 889 | % | 4,772 | 597 | 699 | % | ||||||||||||||||
| Office, insurance, and travel | 799 | 209 | 282 | % | 1,843 | 662 | 178 | % | ||||||||||||||||
| Software and information technology | 125 | 169 | (26 | )% | 544 | 460 | 18 | % | ||||||||||||||||
| Share-based compensation | 185 | (4,904 | ) | n/m | 5,305 | (4,418 | ) | n/m | ||||||||||||||||
| Total | $ | 4,454 | $ | (3,340 | ) | n/m | $ | 16,294 | $ | 539 | 2,923 | % | ||||||||||||
n/m = not meaningful
General and administrative expenses increased to $4.5 million for the three months ended September 30, 2026, from a net recovery of $3.3 million for the three months ended September 30, 2025, primarily driven by an increase in share-based compensation, as the three months ended September 30, 2025 included a gain on the change in fair value of the Company’s stock-based compensation liability due to a significant decline in the estimated fair value of the Company’s liability-classified stock options following the Rights Offering completed in August 2025, which did not recur in the current period. Additionally, general and administrative expenses increased due to professional fees and contractors, including legal, audit, tax and advisory services incurred in connection with the Business Combination that were not directly attributable to the PIPE Financing or to the Subordinate Voting Shares issued in exchange for the net assets of SVIII (which were recorded within temporary equity and equity, respectively), as well as higher public company directors’ and officers’ liability insurance premiums following the Business Combination and increased travel activity.
General and administrative expenses increased to $16.3 million for the nine months ended September 30, 2026, from $0.5 million for the nine months ended September 30, 2025, primarily driven by an increase in share-based compensation, professional fees and contractor expenses, and directors’ and officers’ liability insurance premiums and travel for the same reasons discussed above.
Depreciation and amortization
Depreciation and amortization expense increased 24% to $0.9 million for the three months ended September 30, 2026, from $0.7 million for the three months ended September 30, 2025, and increased 17% to $2.6 million for the nine months ended September 30, 2026, from $2.2 million for the nine months ended September 30, 2025, which primarily reflects a higher depreciable asset base as of September 30, 2026 compared to the prior year due to higher capital asset additions in 2026 as the Company implemented cost control initiatives in early 2025.
Government assistance
Government assistance was $nil for each of the three months ended September 30, 2026 and 2025, and $nil for the nine months ended September 30, 2026, a decrease from $5.9 million for the nine months ended September 30, 2025. The decrease was primarily due to the third amending agreement to the SRF Contribution Agreement, entered into in January 2025, which increased available funding under the agreement from CAD 54.3 million ($38.3 million) to CAD 69.3 million ($48.8 million). During the nine months ended September 30, 2025, the Company received CAD 15.0 million ($10.5 million) in funding under the SRF Contribution Agreement, of which, a portion was recorded as government assistance.
12
Comparatively, government assistance for the nine months ended September 30, 2026 was $nil as the Company had submitted claims up to its maximum available funding under the SRF Contribution Agreement during the year ended December 31, 2025, and the additional CAD 5.0 million ($3.6 million) of funding received under the Amended and Restated SRF Contribution Agreement was fully attributed to the fair value of the warrant consideration, resulting in no residual amount recognized as government assistance.
Interest expense
Interest expense decreased to less than $0.1 million for each of the three and nine months ended September 30, 2026, from $0.2 million and $1.1 million for the three and nine months ended September 30, 2025, respectively, as the Convertible Notes were outstanding during the comparable 2025 periods until their settlement in August 2025.
Interest and other income
Interest and other income increased 762% to $1.2 million for the three months ended September 30, 2026, from $0.1 million for the three months ended September 30, 2025, and increased 594% to $1.9 million for the nine months ended September 30, 2026, from $0.3 million for the nine months ended September 30, 2025, primarily due to higher average cash and cash equivalents on-hand and short-term investments compared to the prior year, resulting in an increase in interest income earned.
Financing costs
Financing costs were $11.5 million for each of the three and nine months ended September 30, 2026, compared to $nil for the comparable periods in 2025. Financing costs represent the portion of the issuance costs of the Business Combination and PIPE Financing, consisting of the fair value of the commitment shares issued to PIPE investors and directly attributable legal and advisory fees, that were allocated to the liability-classified PIPE Warrants and therefore expensed. The portions allocated to the Multiple Voting Shares and Subordinate Voting Shares were recorded as a reduction of equity. Financing costs do not include the transaction-related costs within general and administrative expenses, which are costs of completing the Business Combination not directly attributable to the issuance of securities.
Foreign exchange loss (gain)
Foreign exchange loss increased to $2.1 million for the three months ended September 30, 2026, compared to a foreign exchange gain of $0.1 million for the three months ended September 30, 2025, primarily due to the revaluation of USD cash held within a Canadian functional currency entity, which increased significantly following the receipt of proceeds from the Business Combination and PIPE Financing.
Foreign exchange loss increased to $0.8 million for the nine months ended September 30, 2026, compared to a foreign exchange gain of $1.1 million for the nine months ended September 30, 2025, primarily due to the revaluation of USD cash held within a Canadian functional currency entity. In comparison, for the nine months ended September 30, 2025, the foreign exchange gain is primarily attributable to the revaluation of British pound sterling denominated receivables held within the parent entity of Old General Fusion, which had a Canadian functional currency.
(Gain) on revaluation of convertible notes
The gain on the change in the fair value of the Convertible Notes of $22.5 million and $22.0 million for the three and nine months ended September 30, 2025, respectively, was due to the remeasurement of the Convertible Notes to their fair value upon settlement in August 2025, which was based on the fair value of the Series 2 Class B redeemable convertible preferred shares issued in settlement of the principal and accrued interest. The gain for the nine months ended September 30, 2025 was partially offset by changes in the instrument-specific discount and changes to probabilities of the debt settlement options during the first half of 2025.
13
As the Convertible Notes were settled in August 2025 and the Company did not issue any other convertible debt subsequently, the revaluation amount is $nil for the three and nine months ended September 30, 2026.
Loss (gain) on revaluation of SRF contribution liabilities
The Company recognized a gain on revaluation of SRF contribution liabilities of $20.7 million for the three months ended September 30, 2026 and a loss on revaluation of SRF contribution liabilities of $37.3 million for the nine months ended September 30, 2026. The gain for the three months ended September 30, 2026 is consistent with a decrease in the fair value of the Company’s Subordinate Voting Shares as of September 30, 2026 compared to the estimated fair value as of June 30, 2026. The loss for the nine months ended September 30, 2026 is primarily due to the significant increase in the number of SRF Warrants subject to remeasurement as a result of additional funding received under the Amended and Restated SRF Contribution Agreement and the related warrants issued during the nine months ended September 30, 2026.
In comparison, the Company recognized a gain on revaluation of SRF contribution liabilities of $18.0 million and $19.0 million for the three and nine months ended September 30, 2025, respectively. The gain for the three and nine months ended September 30, 2025 was primarily attributable to a decrease in the estimated fair value of the Company’s common shares following the completion of the Rights Offering in August 2025.
Loss (gain) on revaluation of SAFE liabilities
The Company recognized a gain on revaluation of SAFE liabilities of $2.8 million for the three months ended September 30, 2026, and a loss of $11.1 million for the nine months ended September 30, 2026. The gain for the three months ended September 30, 2026 was primarily due to the final remeasurement of the SAFEs to their settlement value immediately prior to conversion on July 10, 2026, which was based on the quoted share price of the Subordinate Voting Shares of $9.12 at the closing of the Business Combination.
The loss for the nine-month period was primarily due to (i) an increase in the estimated probability of completing the Business Combination, (ii) a decrease in the expected time to the closing of the Business Combination, and (iii) an increase in the estimated fair value of the Company’s common shares relative to December 31, 2025, partially offset by the gain recognized in the third quarter. Following the settlement, no SAFEs remain outstanding as of September 30, 2026.
In comparison, the Company first issued SAFE instruments in November 2025, therefore there was no comparative revaluation gain or loss for the three and nine months ended September 30, 2025.
Loss (gain) on revaluation of PIPE subscription obligation
The Company recognized a gain on revaluation of PIPE subscription obligation of $1.8 million for the three months ended September 30, 2026 and a loss on revaluation of PIPE subscription obligation of $20.3 million for the nine months ended September 30, 2026, which relate to the remeasurement of the PIPE subscription obligation to its estimated fair value. The gain for the three months ended September 30, 2026 is due mainly to a decrease in the estimated fair value of the PIPE subscription obligation through the date of settlement of July 10, 2026 compared to the estimated fair value at June 30, 2026. The loss for the nine months ended September 30, 2026 is due to an increase in the estimated fair value of the PIPE subscription obligation up to July 10, 2026, which was mainly due to an increase in the estimated fair value of the Company’s common shares at the closing of the Business Combination compared to the estimated fair value upon entering into the subscription agreements in January 2026.
In comparison, there is no comparative revaluation gain or loss for the three and nine months ended September 30, 2025 as the PIPE financing was entered into in January 2026.
Gain on revaluation of warrant liabilities
The Company recognized a gain on revaluation of warrant liabilities of $10.3 million and $8.0 million for the three and nine months ended September 30, 2026, respectively, relating to the PIPE Warrants, which were issued upon the closing of the Business Combination on July 10, 2026 in connection with the PIPE Financing and (ii) the Old General Fusion SAFE Warrants, which were exchanged for the SAFE Warrants to purchase Subordinate Voting Shares upon the closing of the Business Combination. The PIPE Warrants and SAFE Warrants are classified as liabilities and remeasured to fair value at each reporting date. The gain for the three months ended September 30, 2026 comprises a gain of $7.4 million on the revaluation of the SAFE Warrants and a gain of $2.9 million on the revaluation of the PIPE Warrants, in each case primarily due to a decrease in the quoted price of the Subordinate Voting Shares from the closing of the Business Combination to September 30, 2026.
14
The gain for the nine months ended September 30, 2026 was partially offset by a loss of $2.3 million on the revaluation of the Old General Fusion SAFE Warrants during the six months ended June 30, 2026, primarily due to an increase in the estimated fair value of the Company’s common shares from $7.49 as of December 31, 2025 to the quoted share price of $9.12 at the closing of the Business Combination.
In comparison, there is no comparative revaluation gain or loss for the three and nine months ended September 30, 2025 as the PIPE Warrants were issued upon the closing of the Business Combination in July 2026 and the Old General Fusion SAFE Warrants were first issued in November 2025.
Gain on revaluation of earnout liabilities
The Company recognized a gain on revaluation of earnout liabilities of $19.4 million for the three and nine months ended September 30, 2026. The Earnout Shares and Earnout Warrants issued upon the closing of the Business Combination vest upon the Subordinate Voting Shares achieving the Earnout Targets or upon a Deemed Liquidation Event during the Earnout Period. The earnout liabilities are classified as liabilities and remeasured to fair value at each reporting date using a Monte Carlo simulation. The gain reflects a decrease in the estimated fair value of the earnout liabilities from $93.8 million at the closing of the Business Combination to $74.4 million as of September 30, 2026, primarily due to a decrease in the quoted price of the Subordinate Voting Shares from the closing of the Business Combination to September 30, 2026.
In comparison, there is no comparative revaluation gain or loss for the three and nine months ended September 30, 2025 as the Earnout Shares and Earnout Warrants were issued upon the closing of the Business Combination.
Liquidity and Capital Resources
As of September 30, 2026, we had cash and cash equivalents of $105.6 million and short-term investments of $35.3 million (December 31, 2025: $49.1 million and $nil, respectively), derived primarily from:
| • | SAFE financings completed in the fourth quarter of 2025 and January 2026, resulting in gross proceeds of $44.5 million; |
| • | the Amended and Restated SRF Contribution Agreement, pursuant to which the Company received an additional funding of CAD 5 million ($3.6 million), in April and May 2026; |
| • | the gross proceeds of PIPE financing of $108.0 million and gross proceeds of $21.7 million from the Business Combination, inclusive of accrued interest on the trust capital funds together with remaining SVIII operating funds before remittance of payables remitted at the source and certain transaction costs. |
To date, we have not generated any revenue, and we have historically incurred losses from operations since our inception. As of September 30, 2026, our accumulated deficit amounted to $544.0 million. We expect to incur significant expenses and operating losses for the foreseeable future as we advance our MTF technology development towards a commercial fusion power plant. In addition, we also expect to incur additional costs associated with operating as a public company such as regulatory fees, transfer agent fees, professional fees and insurance premiums.
Until General Fusion can generate sufficient revenue to fund operating expenses, and capital expenditures, we expect to primarily fund cash needs through a combination of equity and/or debt financing. If we raise funds by issuing equity securities, shareholders will be diluted. Any equity securities issued may also provide for rights, preferences, or privileges senior to the Multiple Voting Shares. If we raise funds by issuing debt securities, the terms of debt securities or borrowings could impose significant restrictions on our operations. We do not expect to generate any revenue from the sale of products or services or from other sources in the near future, if at all.
15
Although we have successfully completed equity and debt financings in the past, there can be no assurance that financings in the future will be successful. The capital markets have in the past, and may in the future, experience periods of upheaval that could impact the availability and cost of equity and debt financing. If we are unable to raise additional capital necessary on acceptable terms to fund our operations and invest in continued innovation, we may need to reconsider our growth plans or limit our research and development activities, which could have a material adverse impact on our business prospects and results of operations.
Based on our current operating plan and estimates, management believes that current cash and cash equivalents and short-term investments will be sufficient to fund our planned operations for at least 12 months from the date of this MD&A.
Cash Flows
We use traditional measures of cash flow, including net cash used in operating activities, net cash used in or provided by investing activities and net cash provided by financing activities to evaluate our periodic cash flow results. Below is a summary of our cash flows for the nine months ended September 30, 2026 and 2025:
| Nine months ended September 30, | ||||||||||||
| (in thousands of dollars) | 2026 | 2025 | $ Change | |||||||||
| Cash flows used in operating activities | (32,616 | ) | (14,345 | ) | (18,271 | ) | ||||||
| Cash flows used in investing activities | (35,842 | ) | (172 | ) | (35,670 | ) | ||||||
| Cash flows provided by financing activities | 127,147 | 22,972 | 104,175 | |||||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (2,608 | ) | 208 | (2,816 | ) | |||||||
| Net change in cash, cash equivalents and restricted cash | 56,081 | 8,663 | 47,418 | |||||||||
Cash flows used in operating activities
General Fusion’s cash flows used in operating activities to date have been primarily comprised of personnel costs, materials and supplies for research and development activities, facilities expense and contractor services related to research and development, business development, marketing, communications and government relations, and general administrative activities. General Fusion intends to continue to grow operations as we pursue our MTF technology development and operate as a public company. Accordingly, we expect cash used in operating activities to increase significantly prior to us generating any cash flows from our operations.
Cash flows used in operating activities were $32.6 million for the nine months ended September 30, 2026, compared to $14.3 million for the nine months ended September 30, 2025, an increase of $18.3 million. The increase was primarily driven by higher operating expenses, a decrease of approximately $5.9 million in government assistance, and a net outflow of $3.2 million from changes in operating assets and liabilities, mainly attributable to an increase in prepaid expenses and other assets. In comparison, changes in operating assets and liabilities resulted in a net outflow of $1.6 million during the nine months ended September 30, 2025, mainly driven by a decrease in accounts payable and accrued liabilities.
Cash flows used in investing activities
Cash flows used in investing activities were $35.8 million for the nine months ended September 30, 2026, compared to $0.2 million for the nine months ended September 30, 2025, with the increase due to the purchase of short-term investments made up of GIC’s with maturities greater than 90 days and less than 1-year using cash proceeds from the closing of the Business Combination and PIPE Financing, and higher capital additions in the current year compared to the relatively limited capital additions in the same period in 2025.
Cash flows provided by financing activities
Our net cash flows provided by financing activities for the nine months ended September 30, 2026 was primarily driven by net proceeds of $123.3 million from the Business Combination and PIPE financing, primarily consisting of (i) $104.6 million from the PIPE financing (gross proceeds of $108.0 million less certain transaction costs) and (ii) $18.7 million representing the balance of SVIII’s trust account of $21.7 million, inclusive of accrued interest and with funds in SVIII’s operating account, less payables remitted at the source and certain transaction costs. Additionally, the Company received proceeds of $3.6 million on the issuance of SRF Preferred Share Warrants pursuant to the Amended and Restated SRF Contribution Agreement.
16
In comparison, for the nine months ended September 30, 2025, the Company received proceeds of $17.0 million from the Rights Offering, plus $1.4 million from a short-term related party loan that was subsequently settled through a subscription to the Rights Offering, as well as $4.6 million of proceeds on the issuance of SRF Warrants pursuant to the SRF Contribution Agreement.
Uses of Liquidity
General Fusion’s principal uses of cash in recent periods have been funding our operations. General Fusion’s future capital requirements will depend on many factors including timing of MTF development, commercialization of MTF and thereafter our revenue growth rate.
Material Contractual Obligations and Commitments
The following table summarizes estimates of undiscounted future cash payments under commitments related to the various agreements that we have entered into as of September 30, 2026.
| (in thousands of dollars) | September 30, 2026 | |||
| Less than 1 year | 838 | |||
| 1 - 3 years | 1,874 | |||
| More than 3 years | 3,089 | |||
| Total | 5,801 | |||
Critical Accounting Policies and Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make judgements, estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reported periods.
We have identified the accounting estimates listed below as critical to understanding and evaluating the financial results reported in our consolidated financial statements. These accounting estimates require the application of significant management judgment and are critical due to the significant level of estimation uncertainty regarding the assumptions involved and the magnitude of the asset, liability, revenue or expense being reported. We base our assumptions and estimates on historical experience and various other sources that we believe to be reasonable under the circumstances. We review the underlying factors used in our estimates regularly, including reviewing the significant accounting policies impacting the estimates, to ensure compliance with U.S. GAAP. However, due to the uncertainty inherent in our estimates, actual results may materially differ from the estimates we calculate.
For a complete summary of all of our significant accounting policies refer to Note 3: Significant Accounting Policies of the notes to the consolidated financial statements for the years ended December 31, 2025 and 2024.
Fair value measurements
Fair value accounting establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value:
| • | (Level 1) - Unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; |
17
| • | (Level 2) - Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and, |
| • | (Level 3) - Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). |
As required by accounting guidance, assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. In addition to unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period.
Following the closing of the Business Combination and the listing of the Subordinate Voting Shares, the share-based compensation liability and the SAFE Warrants, which are presented within warrant liabilities, were transferred from Level 3 to Level 2 during the three months ended September 30, 2026, as the quoted market price of the Subordinate Voting Shares became an observable input. The Company had no material non-financial assets valued on a non-recurring basis that resulted in an impairment in any period presented.
The estimated fair value of the SRF contribution liability is considered a Level 3 fair value measurement due to the use of unobservable inputs, including the probability-weighting of settlement scenarios. The estimated fair values of the share-based compensation liability, warrant liabilities (which include the PIPE Warrants and SAFE Warrants), Earnout Shares and Earnout Warrants are considered Level 2 fair value measurements as of September 30, 2026 due to the use of the quoted market price of the Company’s publicly traded Subordinate Voting Shares, which is an observable input, together with other observable or market-corroborated inputs. Prior to the closing of the Business Combination, the share-based compensation liability and the SAFE Warrants were considered Level 3 fair value measurements due to the use of the estimated per share fair value of the Company’s common shares, and the SAFE liabilities were considered Level 3 fair value measurements due to the probability weighting of future outcomes estimated by management.
The estimated fair values of the convertible notes are considered Level 3 fair value measurements due to the use of the estimated per share fair value of the Company’s preferred shares, which is classified as a Level 3 input within the fair value measurement hierarchy.
As of September 30, 2026, a 20% increase (decrease) in the Company’s share price would have increased (decreased) the estimated fair value of the warrant liabilities by approximately $7.6 million ($7.3 million), resulting in a corresponding loss (gain) on revaluation of warrant liabilities. Similarly, a 10 percent increase (decrease) in the expected volatility assumption would have increased (decreased) the estimated fair value of the warrant liabilities by approximately $5.4 million ($3.7 million), resulting in a corresponding loss (gain) on revaluation of warrant liabilities.
Share-based compensation
We measure share-based awards at fair value on the date of grant and recognize the expense in our consolidated statements of operations and comprehensive loss over the requisite service period of employees and others providing similar services. The fair value of stock options is estimated using the Black-Scholes option pricing model, and the fair value of the Earnout Options and Restricted Earnout Shares issued in connection with the Business Combination is estimated using a Monte Carlo simulation. Liability-classified awards are measured in the same manner as equity-classified awards, except that they are remeasured to fair value at each reporting date through the date of settlement, with changes in fair value recognized in share-based compensation expense within operating loss for the portion of the requisite service period rendered.
Prior to the closing of the Business Combination, U.S. dollar-denominated stock options held by employees paid in Canadian dollars were liability-classified because our shares did not trade in any market. Following the closing on July 10, 2026, the Subordinate Voting Shares trade on Nasdaq in U.S. dollars and these awards are no longer required to be classified as liabilities. We remeasured the liability-classified awards to fair value through the closing date and reclassified the resulting share-based compensation liability of $21.5 million to additional paid-in capital. All outstanding stock options are now equity-classified and are not subsequently remeasured. The Earnout Options remain liability-classified and are remeasured at each reporting date.
18
The Black-Scholes option pricing model requires inputs based on certain subjective assumptions, including the estimated fair value of common shares, expected stock price volatility, the expected term of the award, the risk-free interest rate, and expected dividends. These assumptions involve inherent uncertainties and the application of management’s judgment.
Valuation of the SRF contribution liability
Funds received under the SRF Contribution Agreement and Amended and Restated SRF Contribution Agreement result in the recognition of a financial liability recorded at fair value and the recognition of government assistance. The portion of those funds related to the financial liability is equal to the fair value of the SRF Warrants and SRF Preferred Share Warrants adjusted by the contingent repayment feature with the remaining cash received recorded as government assistance.
The fair value of the SRF contribution liability is estimated using a PWERM, which accounts for the dual-settlement nature of the arrangement by assigning probabilities to discrete future outcomes being the share and cash settlement outcomes. The estimate of the fair value of the SRF Warrants and SRF Preferred Share Warrants is based on the fair value of the underlying securities that the warrants are exercisable into. The fair value of the Contingent Repayment Obligation was estimated using a discounted cash flow model that utilizes debt recovery rates of publicly traded debt as a market proxy of an event of default.
As of September 30, 2026, with other variables unchanged, a 20% increase (decrease) in the Company’s share price would have increased (decreased) the estimated fair value of the SRF contribution liability by approximately $13.5 million ($13.5 million). Similarly, with other variables unchanged, an increase in the estimated probability of cash repayment of amounts received under the SRF Contribution Agreement and Amended and Restated SRF Contribution Agreement from 1% to 5%, with a corresponding decrease in the probability of settlement through the SRF Warrants and SRF Preferred Share Warrants, would have decreased the estimated fair value of the SRF contribution liability by approximately $2.7 million.
Valuation of the SAFE liabilities
Prior to the closing of the Business Combination, the SAFEs were classified as liabilities within the consolidated balance sheets and were measured at fair value at each financial reporting date, with changes in fair value recognized within net loss for the period. The closing on July 10, 2026 constituted a Liquidity Event under the terms of the SAFEs, and all outstanding SAFEs were remeasured to their estimated fair value immediately prior to conversion and reclassified to equity. No SAFE liabilities were outstanding as of September 30, 2026.
The fair value of the SAFEs was estimated using a PWERM, which incorporated management’s assumptions regarding the timing and probability of settlement across four mutually exclusive scenarios: SPAC conversion, IPO conversion, change of control event, and dissolution. The fair value of the SAFE Warrants was estimated via the Monte Carlo simulation model.
Valuation of the Earnout liabilities
The estimated fair value of the Earnout liabilities reflects the probability of achieving each Earnout Target during the Earnout Period, and key inputs include the quoted market price of the Subordinate Voting Shares, expected volatility, the risk-free interest rate and the remaining term of the Earnout Period.
As of September 30, 2026, a 20% increase (decrease) in the Company’s share price would have increased (decreased) the estimated fair value of the Earnout liabilities by approximately $18.0 million ($18.8 million), resulting in a corresponding loss (gain) on revaluation of earnout liabilities. Similarly, a 10 percent increase (decrease) in the expected volatility assumption would have increased (decreased) the estimated fair value of the Earnout liabilities by approximately $2.3 million ($5.2 million), resulting in a corresponding loss (gain) on revaluation of earnout liabilities.
19
Valuation of PIPE Subscription Agreements
Prior to the closing of the Business Combination, the Company’s obligation under the PIPE Subscription Agreements was classified as a liability within the consolidated balance sheets and was measured at fair value at each financial reporting date, with changes in fair value recognized within net loss for the period. The obligation was settled upon the issuance of the PIPE units at closing on July 10, 2026.
The fair value of the PIPE subscription obligation at the date of the agreements and immediately prior to settlement at the closing of the Business Combination was estimated using a Monte Carlo simulation method, measured as the difference between the estimated fair value of the units to be issued and the contractual subscription proceeds to be received. Key assumptions used include the estimated fair value of the post de-SPAC common shares, the expected term, expected volatility, and estimated discount rate.
The PIPE Warrants issued at the closing of the Business Combination remain outstanding and are remeasured at fair value at each reporting date; see “Fair value measurements” above.
Multiple Voting Shares
The Company’s Multiple Voting Shares are classified as temporary equity as they are redeemable at the option of the holder. The Multiple Voting Shares are carried at their redemption value. The Company has elected to recognize changes in the redemption value immediately as they occur such that the carrying amount equals the redemption value at the end of each reporting period. Adjustments to the carrying amount to reflect the redemption value at each reporting date are recognized as deemed dividends and recorded against retained earnings or, where retained earnings are nil or in a deficit position, against additional paid-in capital, with any amount in excess of available additional paid-in capital recorded to accumulated deficit. These adjustments are not recognized in net income (loss); however, they are included in net income (loss) attributable to common shareholders for purposes of calculating earnings (loss) per share.
Related Party Transactions
For transactions with related parties, refer to (i) the consolidated financial statements of Old General Fusion for the years ended December 31, 2025, and 2024 and the related notes thereto, and (ii) the interim condensed consolidated financial statements of the Company for the three and nine months ended September 30, 2026 and 2025, and the related notes thereto, in each case prepared in accordance with U.S. GAAP.
Key Performance Indicators
Management’s key performance indicators primarily relate to the advancement of the LM26 program’s key technical milestones by the end of 2028: plasma heating to 1 keV electron temperature, or 10 million degrees Celsius, then 10 keV temperature, or 100 million degrees, and ultimately, the Lawson criterion.
Key 2025 performance indicators included the LM26 achieving successful commissioning, first plasma and plasma compression. First plasma was achieved in February 2025, demonstrating that all major systems are working as designed, and first plasma compression was achieved in April 2025, validating the integrated performance of the platform.
The key 2026 performance indicator, to date, was the achievement of electron temperatures approximately 1.1 keV, or 12.6 million degrees Celsius, just prior to peak compression, a result measured using Thomson scattering and with the UKAEA, in satisfaction of the Company first technical milestone for the LM26 program.
Recent Accounting Pronouncements
A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note 3: Significant Accounting Policies in the notes to the interim condensed consolidated financial statements for the three and nine months ended September 30, 2026 and 2025.
Quantitative and Qualitative Disclosures About Market Risk
We are exposed to market risk in the ordinary course of our business. Our market risk exposure includes, but is not limited to, liquidity risk, credit risk, interest rate risk, inflation and foreign currency risk.
20
Liquidity Risk
Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company manages liquidity risk through ongoing monitoring of cash flows, budgeting, and maintaining relationships with potential investors and financing partners. Cash flow forecasting is performed regularly to ensure that there is sufficient liquidity to meet short-term business requirements. Refer to the “Liquidity and Capital Resources” section of this MD&A for further discussion regarding the Company’s ability to continue as a going concern.
Credit risk
Credit risk reflects the risk of financial loss to the Company if a counterparty to a financial instrument fails to meet its contractual obligations. This risk arises principally in respect of the Company’s cash and cash equivalents. The majority of the Company’s bank balances are uninsured as of September 30, 2026. In order to mitigate its exposure to credit risk, the Company monitors its financial assets and maintains substantially all of cash deposits in a Schedule I chartered bank in Canada. The Company does not consider any of its financial assets to be impaired as of September 30, 2026.
Interest Rate Risk
As of September 30, 2026, we had cash and cash equivalents of $105.6 million, consisting of cash on deposit and guaranteed investment certificates, and short-term investments of $35.3 million, consisting of non-redeemable guaranteed investment certificates with original maturities of greater than three months, but less than one year held with a Canadian chartered bank. Interest earned on these balances would be affected by a change in the general level of interest rates. Interest income is sensitive to changes in the general level of interest rates. We have not entered into investments for trading or speculative purposes. Due to the conservative nature of our investments, which is predicated on capital preservation of investments with short-term maturities, we do not believe an immediate 10% change in interest rates would have a material effect on the fair market value of our investment portfolio.
As of September 30, 2026, we had no long-term debt outstanding, and therefore we are not subject to interest rate risk related to debt.
Foreign Currency Risk
Foreign currency risk exposures arise from transactions denominated in a currency other than the functional currency of our legal entities. Our foreign currency risk arises primarily with respect to USD denominated balances in our Canadian functional currency entity. Based on the Company’s USD denominated monetary assets and monetary liabilities as of September 30, 2026, a 10% increase (decrease) in the USD relative to the CAD would increase (decrease) the Company’s net loss by approximately $3.3 million (CAD 4.6 million).
Effects of Inflation
Inflation generally affects us by increasing our labor and materials costs. Although we do not believe that inflation has had a material impact on our financial position or results of operations to date, we may experience some effect in the near future (especially if inflation rates continue to rise) due to an impact on the costs to advance our research and development, including labor and materials costs, and other operational costs. An inflationary environment could adversely affect our business, financial condition and results of operations.
Capital Management
The Company’s objectives in managing capital are to safeguard the ability to continue as a going concern and provide financial capacity to meet its strategic objectives. Management monitors the amount of cash and cash equivalents and equity in the capital structure and adjusts the capital structure, as necessary, to continue as a going concern and to support our research and development activities. To maintain or adjust the capital structure, the Company may issue new preferred or common shares of the Company, and/or issue new debt.
Forecasts are regularly reviewed and updated for changes in circumstances so that appropriate capital allocation, investment and financing decisions are made for the Company.
21
Non-GAAP Measures
This MD&A makes reference to a financial measure not recognized under U.S. GAAP, being “Adjusted Operating Loss”. This measure does not have any standardized meaning prescribed within U.S. GAAP and, therefore, may not be comparable to similar measures presented by other companies. This measure is provided as additional information to complement U.S. GAAP measures by providing a further understanding of General Fusion’s financial performance from management’s perspective. This non-GAAP measure excludes government assistance and non-cash expenses, specifically share-based compensation, and depreciation and amortization. General Fusion does not believe that such items directly reflect General Fusion’s core operations and may therefore not be indicative of its recurring operating costs.
General Fusion’s management uses this measure to assess General Fusion’s performance, identify trends affecting General Fusion’s business, formulate business plans, and make strategic decisions.
Adjusted Operating Loss should be considered in addition to, not as a substitute for or in isolation from, our financial results prepared in accordance with GAAP. In addition, our presentation of Adjusted Operating Loss may be different from how such a metric is used by other companies.
A reconciliation of Adjusted Operating Loss to Operating loss (income) for the three and nine months ended September 30, 2026 and 2025 is set forth below:
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||
(in thousands of dollars, except percentages) | 2026 | 2025 | % Change | 2026 | 2025 | % Change | ||||||||||||||||||
| Operating loss (income) | $ | 12,387 | $ | (243 | ) | n/m | $ | 40,498 | $ | 10,128 | 300 | % | ||||||||||||
| Share-based compensation | (480 | ) | 6,244 | (108 | )% | (8,419 | ) | 5,144 | (264 | )% | ||||||||||||||
| Government assistance | - | - | n/m | - | 5,921 | n/m | ||||||||||||||||||
| Depreciation and amortization | (862 | ) | (696 | ) | 24 | % | (2,584 | ) | (2,205 | ) | 17 | % | ||||||||||||
| Adjusted Operating Loss | $ | 11,045 | $ | 5,305 | 108 | % | $ | 29,495 | $ | 18,988 | 55 | % | ||||||||||||
n/m = not meaningful
Disclosure Controls and Procedures and Internal Control Over Financial Reporting
In the course of the external audit of Old General Fusion’s financial statements for the years ended December 31, 2025 and 2024, Old General Fusion identified material weaknesses in our internal control over financial reporting. Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with the applicable accounting standards, which for us is U.S. GAAP.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.
In connection with the preparation of its consolidated financial statements as of December 31, 2025 and 2024 for the years ended December 31, 2025 and 2024, Old General Fusion identified the following material weaknesses in its internal control over financial reporting: (i) lack of formalized policies, procedures and controls: Old General Fusion lacked adequate documentation across key processes and did not design and maintain adequate formal documentation of its internal control procedures and policies including an absence of an internal process to identify and assess deficiencies in its internal controls on a timely basis; (ii) lack of IT General Controls: Old General Fusion lacks adequate information technology general controls over its key financial reporting systems, including ineffective segregation of duties, change management and program development in its control environment; and (iii) lack of qualified personnel: Old General Fusion did not maintain a sufficient complement of personnel with requisite knowledge and experience in the application of complex areas of U.S. GAAP and SEC rules to appropriately present certain complex and non-routine debt and government assistance transactions in conformity with U.S. GAAP and its internal review process lacked the requisite knowledge to effectively monitor the work of third-party consultants and ensure compliance with U.S. GAAP and SEC reporting requirements.
22
We are in the process of implementing measures designed to improve our internal control over financial reporting and remediate these material weaknesses. Such measures include, but are not limited to: designing and implementing our financial control framework to identify, assess, and respond to the risks of material misstatement; designing and implementing certain information technology general controls over our information technology systems with the assistance of external advisors with the requisite experience and knowledge; adding additional qualified accounting personnel with experience with complex GAAP and SEC rules; and engaging an accounting advisory firm to assist with the documentation, evaluation, remediation and testing of our internal control over financial reporting based on the criteria established in ‘‘Internal Control — Integrated Framework (2013)’’ issued by the Committee of Sponsoring Organizations of the Treadway Commission.
If these deficiencies are not remediated or if additional deficiencies are identified in the future, it could result in material misstatements in our financial statements that would not be prevented or detected and impair General Fusion’s ability to comply with applicable financial reporting requirements and related regulatory filings on a timely basis. Moreover, ineffective internal control over financial reporting could significantly hinder our ability to prevent fraud.
While we are currently implementing these remediation measures, they have not been fully implemented and assessed, and therefore the material weaknesses remain as at September 30, 2026. Notwithstanding these identified material weaknesses, we believe that our interim financial statements present fairly, in all material respects, our business, financial condition and results of operations for the periods presented.
SVIII identified a material weakness in its internal control over financial reporting relating to the design and operation of review controls over the valuation of complex financial instrument, which resulted in the restatement of SVIII’s unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2026, as previously disclosed in Amendment No. 1 to SVIII’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. The restatement related solely to SVIII’s historical financial statements and did not affect the historical financial statements of Old General Fusion, which, as the accounting acquirer in the reverse recapitalization, are the historical financial statements of the Company. Following the closing of the Business Combination on July 10, 2026, SVIII’s pre-closing financial reporting processes and controls were discontinued and replaced by those of the Company. Management has considered the SVIII material weakness in evaluating the Company’s internal control over financial reporting as of September 30, 2026, and believes that the risks to which it related are addressed by the remediation measures described above, including those relating to the application of complex areas of U.S. GAAP to non-routine transactions, including the valuation of complex financial instruments.
Except for the changes resulting from the Business Combination described above, pursuant to which the Company’s internal control over financial reporting became that of Old General Fusion, and the ongoing implementation of the remediation measures described above, there were no changes in our internal control over financial reporting during the three month period ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
General Fusion is subject to the Sarbanes-Oxley Act of 2002 (“SOX”), and Section 404(a) of SOX requires management to assess and report on the effectiveness of General Fusion’s internal control over financial reporting in its annual report on Form 20-F, beginning with the annual report for the fiscal year ending December 31, 2026.
Emerging Growth Company Status
General Fusion is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933 (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. General Fusion has elected to not opt out of such extended transition period.
23
Outstanding Share Information
As of September 30, 2026, General Fusion had outstanding share capital consisting of (i) 53,132,058 Subordinate Voting Shares, (ii) 10,416,663 Multiple Voting Shares, which are convertible into Subordinate Voting Shares and (iii) 9,519,205 Earnout Shares, each of which converts into one Subordinate Voting Share upon the achievement of the Earnout Targets during the Earnout Period, and otherwise having the rights and restrictions set forth in the articles of General Fusion.
In addition, as of September 30, 2026, General Fusion had (i) 7,335,962 options outstanding, each of which is exercisable for one Subordinate Voting Share and 1,516,518 Earnout Options and Restricted Earnout Shares, (ii) 38,360,095 warrants outstanding, each of which is exercisable for one Subordinate Voting Share and 2,459,745 Earnout Warrants
As of November 13, 2026, General Fusion had outstanding share capital consisting of (i) 53,132,058 Subordinate Voting Shares, (ii) 10,416,663 Multiple Voting Shares, which are convertible into Subordinate Voting Shares and (iii) 9,519,205 Earnout Shares.
In addition, as of November 13, 2026, General Fusion had (i) 7,385,962 options outstanding, each of which is exercisable for one Subordinate Voting Share and 1,516,518 Earnout Options and Restricted Earnout Shares, (ii) 38,360,095 warrants outstanding, each of which is exercisable for one Subordinate Voting Share and 2,459,745 Earnout Warrants.
Cautionary Note Regarding Forward-Looking Statements
This MD&A contains forward-looking statements within the meaning of the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and forward-looking information within the meaning of applicable Canadian securities laws (collectively, “forward-looking statements”).
Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. Forward-looking statements reflect our current views with respect to, among other things, the future demand for fusion energy, our capital resources, business strategy, technology development plans, performance and results of operations. In some cases, you can identify these forward-looking statements by the use of terminology such as “outlook,” “believes,” “expects,” “expected,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates,” “anticipated,” “projected,” “future” or the negative version of these words or other comparable words or phrases.
The forward-looking statements contained in this MD&A reflect our current views about future events and are subject to numerous known and unknown risks, uncertainties, assumptions and changes in circumstances that may cause actual results to differ significantly from those expressed in any forward-looking statement. In particular, this MD&A contains forward-looking statements pertaining to our consolidated capitalization; the development, demonstration and commercialization of our approach to MTF, including the objectives and expected timeline of the LM26 program; our ability to achieve technology development milestones; the potential market opportunity for fusion energy and clean energy technology; our ability to obtain and maintain government funding, contracts, awards and other strategic relationships; our future capital requirements and sources and uses of cash; our ability to obtain additional financing for our operations and growth; our expectations regarding applicable energy, nuclear, environmental and other regulatory frameworks; our ability to attract and retain qualified scientists, engineers, employees and management; our ability to obtain and maintain intellectual property protection and avoid infringing the rights of others; expectations regarding the period during which we will qualify as an emerging growth company under the JOBS Act; and the outcome of any known and unknown litigation and regulatory proceedings.
24
We do not guarantee that the events described will happen as described (or that they will happen at all). The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements:
| • | the risk that capital needed by the Company may not be raised on favorable terms, or at all; |
| • | the risk that the trading in our securities may be volatile due to limited volume and the release of a substantial number of Subordinate Voting Shares from a lock-up expiring 180 days after the closing date of the Business Combination; |
| • | general economic, financial market and geopolitical conditions, including conditions affecting capital markets and the clean energy sector; |
| • | the risk of substantial dilution upon a reduction in the exercise or conversion price of the Multiple Voting Shares and PIPE Warrants in accordance with the terms thereof; |
| • | our status as a development-stage company with a history of losses, no revenue from commercial fusion energy operations and no assurance of achieving profitability; |
| • | our ability to develop, demonstrate and commercialize MTF technology on the expected timeline or at all, including any failure to achieve the technical objectives of the LM26 program; |
| • | the scientific, engineering and technical challenges inherent in developing fusion energy technology and the possibility that our technology may not be technically or commercially viable; |
| • | our ability to maintain and enter into new contracts, grants, awards and other relationships with governments, government entities, strategic partners, suppliers and other third parties; |
| • | the impact of and changes in laws and regulations governing fusion energy research, development, demonstration and commercialization, including nuclear energy, environmental, export control and other regulatory frameworks; |
| • | our ability to attract and retain qualified scientists, engineers, employees and management; |
| • | our ability to maintain the listing of the Subordinate Voting Shares Public Warrants on the Nasdaq; |
| • | the volatility of the market price and liquidity of the Subordinate Voting Shares and Public Warrants; |
| • | competition from other fusion energy companies and from other clean energy, conventional energy and energy storage technologies; |
| • | our ability to obtain, maintain, protect and enforce intellectual property rights in our technology and to avoid infringing, misappropriating or otherwise violating the intellectual property rights of others; |
| • | limited supply of specialized materials, components and equipment, dependence on key suppliers and potential supply chain disruptions; |
| • | the effects of climate change, extreme weather events, water scarcity, seismic events and other physical risks on our operations, facilities and supply chain; |
| • | fluctuations in foreign currency exchange rates, particularly fluctuations in the Canadian dollar relative to the U.S. dollar; |
| • | the effectiveness of our internal controls and disclosure controls and procedures as a newly public company; |
| • | the limited experience of certain members of our management team in operating a public company listed in the United States; |
| • | any reduction in the period during which we will qualify as an emerging growth company under the JOBS Act; |
| • | potential litigation, governmental or regulatory proceedings, investigations or inquiries involving us, including in relation to the Business Combination, our technology or our operations; and |
| • | risks related to the development, demonstration, commercialization and scale-up of our technology and the need to obtain required approvals from regulatory authorities. |
The forward-looking statements contained herein may prove incorrect and are expressly qualified by the cautionary statements contained or incorporated by reference in this MD&A. These forward-looking statements speak only as of the date of this MD&A and are subject to risks, uncertainties and other factors, many of which are outside our control, that could cause actual results to differ materially from future results expressed, projected or implied by the forward-looking statements. For a further discussion of the risks and other factors that could cause our future results, performance, business, financial condition, prospects, development milestones or transactions to differ significantly from those expressed in any forward-looking statements, including risks relating to our status as a development-stage fusion energy technology company, our ability to develop and commercialize MTF technology, the LM26 program, our capital requirements and financing needs, regulatory developments, government funding and strategic relationships, please see the section entitled “Risk Factors” in our F-1 and prospectus. There may be additional risks that we do not presently know or that we currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements.
25
Such forward-looking statements are based on a number of estimates and assumptions that we believe are reasonable when made including, but not limited to: our ability to execute our business plan and technology roadmap; our ability to achieve the expected objectives and timing of the LM26 program; the availability of capital and other financing on acceptable terms; the availability of government funding, contracts, grants, awards and strategic relationships; the continued availability of key personnel, suppliers, specialized materials and equipment; the development of applicable fusion energy, nuclear, environmental, export control and other regulatory frameworks; assumptions that none of the risks identified in our F-1 and prospectus materialize; that there are no unforeseen changes to economic, market, regulatory, technological or competitive conditions; and that no significant events occur outside the ordinary course of business. Such estimates and assumptions are made in light of the experience of management and its perception of historical trends, current conditions and expected future developments, as well as other factors believed to be appropriate and reasonable in the circumstances. However, there can be no assurance that such estimates and assumptions will prove to be correct.
Should one or more of these risks or uncertainties materialize, or should any of the assumptions made in connection with these forward-looking statements prove incorrect, actual results may vary in material respects from those projected in the forward-looking statements. Neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Moreover, the forward-looking statements made in this MD&A relate only to events as of the date on which the statements are made. Except as required by applicable law, we do not undertake to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this MD&A, including information regarding the Business Combination, our business and technology development plans, and the regulatory and market environment in which we operate. While we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, these forward-looking statements should not be relied upon as guarantees of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual future results, levels of activity, performance, development milestones, technology readiness, regulatory outcomes, financing availability and other events and circumstances could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving and highly technical industry, and new risks and uncertainties may emerge from time to time. Management cannot predict all risks and uncertainties.
26